Up­dat­ed: Trump ad­min­is­tra­tion halts more than $750M in funds for Mod­er­na’s bird flu vac­cine

2 days ago
Pharma
Coronavirus

The fate of Mod­er­na’s next-gen Covid shot looms large af­ter a flur­ry of pol­i­cy changes

2 days ago
R&D
FDA+

No­vo Nordisk ‘strong­ly’ urges against phar­ma tar­iffs as com­ments flood in

2 days ago
Pharma
Manufacturing

In­sur­ance start­up De­vot­ed Health cuts 5% of work­ers in small lay­off

2 days ago
People
Startups

GSK, Spero re­port Phase 3 win for UTI an­tibi­ot­ic; Sper­o's stock soars

2 days ago
R&D

Weeks af­ter TIG­IT fail, iTeos de­cides to wind down

2 days ago
People
Startups

Veru’s obe­si­ty drug rough­ly as safe as We­govy; Keros’ board fight

2 days ago
News Briefing

A new dawn for psy­che­delics? Com­pass could be the first to find out

2 days ago
Pharma
In Focus

Post-Hoc Live: Is biotech sen­ti­ment re­al­ly as bad as it seems? 

2 days ago
Financing
Deals

Strand Ther­a­peu­tics re­ports promis­ing start for mR­NA can­cer ther­a­py

2 days ago
R&D

Up­dat­ed: MD An­der­son-al­lied in­vest­ment firm tar­gets $250M for sec­ond can­cer biotech fund

2 days ago
Financing
Startups

In­flaRx cans Go­hibic de­vel­op­ment af­ter skin dis­ease tri­al stopped for fu­til­i­ty

2 days ago
R&D

Ax­some and Het­ero set­tle patent fight over sleep dis­or­der drug

3 days ago
Pharma
Law

No­var­tis won bid­ding war for kid­ney drug as Reg­u­lus' top three ex­ecs ex­pect to make over $100M com­bined

3 days ago
Deals

FDA lead­er­ship preps for sum­mer bio­phar­ma lis­ten­ing tour across six cities

3 days ago
FDA+

FDA re­jects Savara’s rare lung dis­ease drug over lim­it­ed man­u­fac­tur­ing da­ta

3 days ago
Pharma
FDA+

Ser­no­va chair re­signs fol­low­ing in­sid­er trad­ing in­dict­ment over No­var­tis-Chi­nook deal

3 days ago
People
Law

Bound­less Bio changes plans for can­cer drug af­ter tox­i­c­i­ty is­sues

3 days ago
People
R&D

RFK Jr. ends an­nu­al Covid vac­cine rec­om­men­da­tions for kids, preg­nant women

3 days ago
FDA+

Lil­ly to buy non-opi­oid pain biotech SiteOne for up to $1B

3 days ago
Deals
Pharma

Liq­uidia wins ap­proval for in­haled hy­per­ten­sion drug in two set­tings, fur­ther­ing ri­val­ry with Unit­ed Ther­a­peu­tics

3 days ago
Pharma
FDA+

ITM re­veals up to $262M debt fi­nanc­ing; Caris Life Sci­ences to go pub­lic

3 days ago
News Briefing

Gil­gamesh’s short-act­ing psy­che­del­ic drug shows rapid ef­fect in Phase 2 de­pres­sion study

3 days ago
R&D

Bio­gen taps City Ther­a­peu­tics in RNAi deal worth up to $1B

3 days ago
Startups
Deals
First page Previous page 12345 Next page Last page
A service from the Financial Times